Here are five things to know.
1. Total revenue for the first quarter of 2018 was $12.1 million, a 23.9 percent increase from $9.8 million for the same period in 2017.
2. Gross profit for the first quarter of 2018 was $8.9 million, a 20.3 percent increase compared to $7.4 million for the same period last year. Gross profit margin for the first quarter of 2018 was 73.7 percent, compared to 76 percent for the same period last year; it was mostly driven by a higher mix of international revenue, including instrument set sales.
3. Total operating expenses for the first quarter of 2018 were $13.3 million, a 61.3 percent increase from $8.3 million for the same period in 2017. OrthoPediatrics became a public company in October 2017.
4. The company added nine incremental U.S. sales representatives in the first quarter 2018 for a total of 84, ahead of the 18 planned additions for the full year 2018.
5. Property and equipment purchases during the first quarter of 2018 were $2.8 million, a 108 percent increase from $1.3 million for the same period last year. This was mostly due to the deployment of $5.5 million of consigned sets.
More articles on devices:
OrthoPediatrics receives FDA clearance for 25th surgical system: 3 insights
3M warming system in hot water over allegedly causing joint infections: 5 takeaways
DePuy Synthes launches new arthroscopic system: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
